Seropositive Rheumatoid Arthritis Diagnosis and Treatment

Diagnosis Criteria

The American College of Rheumatology requires at least 1:80 ANA titer to even begin considering SLE, and even at 1:160 the specificity only reaches 86.2% 2
The markedly elevated RF and ESR with joint pain is the classic triad for seropositive RA, not lupus 1
Joint involvement, such as 4-10 small joints involved, is worth 3 points in the RA diagnostic score 1
Serology, such as high positive RF, is worth 3 points in the RA diagnostic score 1
Acute phase reactants, such as ESR 91, is worth 1 point in the RA diagnostic score 1
Duration of symptoms, such as ≥6 weeks, is worth 1 point in the RA diagnostic score 1

The American College of Rheumatology recommends methotrexate 15 mg weekly as first-line therapy for seropositive RA 1, 3
Methotrexate should be started immediately after confirming clinical synovitis, with a plan to escalate to 20-25 mg weekly based on response 1, 3
Folic acid 1 mg daily should be given to reduce methotrexate toxicity 1
Prednisone 10-20 mg daily should be given as bridge therapy for 4-8 weeks, then taper 1, 3

The treatment target is remission (SDAI ≤3.3) or low disease activity (SDAI ≤11) 1
Disease activity should be reassessed every 4-6 weeks using SDAI with 28-joint count 1
CRP and ESR should be repeated at each visit to monitor inflammatory activity 1
Hand, wrist, and foot X-rays should be repeated at 6 months and 12 months to assess radiographic progression 1
High RF titer (255) predicts more aggressive disease 1
Markedly elevated ESR (91) indicates severe systemic inflammation 1
Early referral to rheumatology is mandatory (within 6 weeks of symptom onset if possible) as early treatment prevents irreversible joint damage 1